Bolt Biotherapeutics Inc.

22.36-1.97-8.10%Vol 206.01K1Y Perf -30.64%
Apr 16th, 2021 16:00 DELAYED
BID21.47 ASK26.27
Open24.27 Previous Close24.33
Pre-Market- After-Market-
 - -  - -%
Target Price
41.00 
Analyst Rating
— — 0.00
Potential %
83.36 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap812.29M 
Earnings Rating
Price Range Ratio 52W %
6.71 
Earnings Date
-

Today's Price Range

21.3524.27

52W Range

20.8743.07

Summary:

Neutral

Technical Indicators: Sell
Moving Averages: Neutral
Performance
1 Week
-3.58%
1 Month
-44.00%
3 Months
-
6 Months
-
1 Year
-30.64%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
BOLT22.36-1.9700-8.10
AAPL134.16-0.3400-0.25
GOOG2 297.761.10000.05
MSFT260.741.24000.48
XOM56.66-0.3200-0.56
WFC43.841.60003.79
JNJ162.241.85001.15
FB306.18-1.6400-0.53
GE13.39-0.1600-1.18
JPM153.301.13000.74
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.72-7.95-1 004.17
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume206.01K
Shares Outstanding36.33M
Trades Count2.63K
Dollar Volume4.00M
Avg. Volume307.84K
Avg. Weekly Volume141.60K
Avg. Monthly Volume304.69K
Avg. Quarterly Volume307.84K

Bolt Biotherapeutics Inc. (NASDAQ: BOLT) stock closed at 22.36 per share at the end of the most recent trading day (a -8.1% change compared to the prior day closing price) with a volume of 206.38K shares and market capitalization of 812.29M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 63 people. Bolt Biotherapeutics Inc. CEO is Randall C. Schatzman.

The one-year performance of Bolt Biotherapeutics Inc. stock is -30.64%, while year-to-date (YTD) performance is %. BOLT stock has a five-year performance of %. Its 52-week range is between 20.87 and 43.07, which gives BOLT stock a 52-week price range ratio of 6.71%

Bolt Biotherapeutics Inc. currently has a PE ratio of -12.40, a price-to-book (PB) ratio of -, a price-to-sale (PS) ratio of 3 434.64, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -122.33%, a ROC of -% and a ROE of 78.43%. The company’s profit margin is -%, its EBITDA margin is -13 946.30%, and its revenue ttm is $231.00 Thousand , which makes it $0.01 revenue per share.

Of the last four earnings reports from Bolt Biotherapeutics Inc., there were 0 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Bolt Biotherapeutics Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Bolt Biotherapeutics Inc. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Bolt Biotherapeutics Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Bolt Biotherapeutics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Bolt Biotherapeutics Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 16.01, ATR14 : 1.95, CCI20 : -92.91, Chaikin Money Flow : -0.37, MACD : -2.99, Money Flow Index : 38.82, ROC : -19.77, RSI : 54.52, STOCH (14,3) : 11.90, STOCH RSI : 0.47, UO : 42.05, Williams %R : -88.10), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Bolt Biotherapeutics Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems.

CEO: Randall C. Schatzman

Telephone: +1 650 665-9295

Address: 900 Chesapeake Drive, Redwood 94063, CA, US

Number of employees: 63

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

67%33%

Bearish Bullish

67%33%

News

Stocktwits